TEL AVIV, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced ...
(RTTNews) - Entera Bio Ltd. (ENTX) has appointed Geno J. Germano, a veteran biopharmaceutical leader with senior roles at Pfizer, Wyeth and Intrexon, as Chairman of its Board of Directors. His ...
This appointment reflects a shared mission with Lucid Group to transform lives by ensuring innovative medicine doesn't stop at approval but reaches the patients who need it most. His leadership marks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results